Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Mi-Heon Lee"'
Autor:
Li X. Zhu, Tonya C. Walser, Linh M. Tran, Kostyantyn Krysan, Michael C. Fishbein, Jerry W. Shay, Zhe Jing, Jill E. Larsen, Ying Q. Lin, Mi Heon Lee, Long sheng Hong, Steven M. Dubinett, John D. Minna, Sherven Sharma, Brigitte N. Gomperts, John A. Belperio, Aik Ooi, Natalie Yakobian, Gerald Wang
Publikováno v:
Cancer research, vol 78, iss 8
Epithelial-to-mesenchymal transition (EMT) is organized in cancer cells by a set of key transcription factors, but the significance of this process is still debated, including in non–small cell lung cancer (NSCLC). Here, we report increased express
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::abff79006384b38e02471c369fde37dd
https://europepmc.org/articles/PMC5899686/
https://europepmc.org/articles/PMC5899686/
Autor:
Kachroo, Puja1,2,3 puja.kachroo@gmail.com, Mi-Heon Lee1,3 mi-heonlee@mednet.ucla.edu, Ling Zhang1,3 lizhang@llu.edu, Baratelli, Felicita1,2 felicita.baratelli@gmail.com, Gina Lee1,2 leex0455@umn.edu, Srivastava, Minu K.1,4 msrivastava@mednet.ucla.edu, Wang, Gerald1,2 geraldwang@mednet.ucla.edu, Walser, Tonya C.1,2 twalser@mednet.ucla.edu, Krysan, Kostyantyn1,2 kkrysan@mednet.ucla.edu, Sharma, Sherven1,4 ssharma@mednet.ucla.edu, Dubinett, Steven M.1,2,4 sdubinett@mednet.ucla.edu, Lee, Jay M.1,2,3,5 jaymoonlee@mednet.ucla.edu
Publikováno v:
Journal of Experimental & Clinical Cancer Research (17569966). 2013, Vol. 32 Issue 1, p1-28. 28p.
Autor:
Sherven Sharma, Paul Pagano, Kostyantyn Krysan, Steven M. Dubinett, Gerald Wang, Mi-Heon Lee, Jane Yanagawa, Jay M. Lee, Maie A. St. John, Tonya C. Walser, Puja Kachroo
Publikováno v:
Lee, M-H; Kachroo, P; Pagano, PC; Yanagawa, J; Wang, G; Walser, TC; et al.(2014). Combination Treatment with Apricoxib and IL-27 Enhances Inhibition of Epithelial-Mesenchymal Transition in Human Lung Cancer Cells through a STAT1 Dominant Pathway.. Journal of cancer science & therapy, 6(11), 468-477. doi: 10.4172/1948-5956.1000310. UCLA: Retrieved from: http://www.escholarship.org/uc/item/4q6540ds
Journal of cancer science & therapy, vol 6, iss 11
Journal of cancer science & therapy, vol 6, iss 11
BackgroundThe cyclooxygenase 2 (COX-2) pathway has been implicated in the molecular pathogenesis of many malignancies, including lung cancer. Apricoxib, a selective COX-2 inhibitor, has been described to inhibit epithelial-mesenchymal transition (EMT
Autor:
Gerald Wang, Mi Heon Lee, Felicita Baratelli, Ling Zhang, Steven M. Dubinett, Sherven Sharma, Tonya C. Walser, Puja Kachroo, Gina Lee, Jay M. Lee, Minu K. Srivastava, Kostyantyn Krysan
Publikováno v:
Kachroo, Puja; Lee, Mi-Heon; Zhang, Ling; Baratelli, Felicita; Lee, Gina; Srivastava, Minu K; et al.(2013). IL-27 inhibits epithelial-mesenchymal transition and angiogenic factor production in a STAT1-dominant pathway in human non-small cell lung cancer. Journal of Experimental & Clinical Cancer Research, 32(1), 97. doi: http://dx.doi.org/10.1186/1756-9966-32-97. Retrieved from: http://www.escholarship.org/uc/item/2zr912pg
Journal of Experimental & Clinical Cancer Research : CR
Kachroo, P; Lee, MH; Zhang, L; Baratelli, F; Lee, G; Srivastava, MK; et al.(2013). IL-27 inhibits epithelial-mesenchymal transition and angiogenic factor production in a STAT1-dominant pathway in human non-small cell lung cancer. Journal of Experimental and Clinical Cancer Research, 32(1). doi: 10.1186/1756-9966-32-97. UCLA: Retrieved from: http://www.escholarship.org/uc/item/38f8k949
Journal of Experimental & Clinical Cancer Research : CR
Kachroo, P; Lee, MH; Zhang, L; Baratelli, F; Lee, G; Srivastava, MK; et al.(2013). IL-27 inhibits epithelial-mesenchymal transition and angiogenic factor production in a STAT1-dominant pathway in human non-small cell lung cancer. Journal of Experimental and Clinical Cancer Research, 32(1). doi: 10.1186/1756-9966-32-97. UCLA: Retrieved from: http://www.escholarship.org/uc/item/38f8k949
Background Interleukin-27 signaling is mediated by the JAK-STAT pathway via activation of STAT1 and STAT3, which have tumor suppressive and oncogenic activities, respectively. Epithelial–mesenchymal transition (EMT) and angiogenesis are key process
Autor:
Puja Kachroo, Sherven Sharma, Gina Lee, Jay M. Lee, Kostyantyn Krysan, Sara Zaknoen, Tonya C. Walser, Mi-Heon Lee, Steven M. Dubinett
Publikováno v:
Cancer Research. 72:339-339
Introduction The cyclooxygenase 2 (COX-2) pathway has been implicated in the molecular pathogenesis of many cancers. Apricoxib, a selective COX-2 inhibitor, has recently been demonstrated to inhibit epithelial to mesenchymal transition (EMT) in human